MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,692,218 | +171.7% | 2,059,050 | +125.4% | 1.91% | +218.7% |
| Q2 2023 | $33,010,175 | -16.5% | 913,650 | -14.1% | 0.60% | -22.9% |
| Q1 2023 | $39,546,507 | -32.0% | 1,063,650 | -17.1% | 0.78% | -30.3% |
| Q4 2022 | $58,164,085 | -41.3% | 1,283,692 | -9.5% | 1.11% | -39.5% |
| Q3 2022 | $99,095,000 | +35.4% | 1,418,892 | +30.1% | 1.84% | +38.8% |
| Q2 2022 | $73,199,000 | -45.4% | 1,090,400 | -33.1% | 1.33% | -39.0% |
| Q1 2022 | $134,060,000 | -35.9% | 1,630,500 | +14.3% | 2.17% | -19.2% |
| Q4 2021 | $209,239,000 | -13.9% | 1,426,400 | +3.9% | 2.69% | +0.7% |
| Q3 2021 | $242,933,000 | +19.0% | 1,373,200 | +8.6% | 2.67% | +29.3% |
| Q2 2021 | $204,206,000 | -2.4% | 1,264,200 | +3.5% | 2.06% | +5.6% |
| Q1 2021 | $209,192,000 | -16.8% | 1,221,200 | +6.6% | 1.96% | -11.1% |
| Q4 2020 | $251,554,000 | +15.0% | 1,145,300 | -13.0% | 2.20% | -19.9% |
| Q3 2020 | $218,688,000 | +44.7% | 1,317,000 | -0.5% | 2.75% | +29.2% |
| Q2 2020 | $151,172,000 | +38.2% | 1,324,100 | -7.0% | 2.13% | +15.7% |
| Q1 2020 | $109,409,000 | -36.7% | 1,423,300 | +6.2% | 1.84% | -25.4% |
| Q4 2019 | $172,750,000 | +314.3% | 1,340,600 | +150.5% | 2.47% | +211.8% |
| Q3 2019 | $41,693,000 | +884.7% | 535,143 | +170.5% | 0.79% | +1657.8% |
| Q1 2016 | $4,234,000 | +315.9% | 197,859 | +514.5% | 0.04% | +400.0% |
| Q4 2015 | $1,018,000 | -87.7% | 32,200 | -86.6% | 0.01% | -89.2% |
| Q3 2015 | $8,261,000 | -61.4% | 240,000 | -64.7% | 0.08% | -47.1% |
| Q2 2015 | $21,415,000 | -42.4% | 680,500 | -46.3% | 0.16% | -50.5% |
| Q1 2015 | $37,148,000 | +71.9% | 1,267,000 | +8.6% | 0.32% | +53.1% |
| Q4 2014 | $21,613,000 | +5.8% | 1,167,000 | 0.0% | 0.21% | -2.8% |
| Q3 2014 | $20,434,000 | -12.8% | 1,167,000 | -0.4% | 0.21% | -22.5% |
| Q2 2014 | $23,440,000 | -3.5% | 1,172,000 | -8.0% | 0.28% | -8.0% |
| Q1 2014 | $24,302,000 | +14.7% | 1,274,332 | 0.0% | 0.30% | -3.9% |
| Q4 2013 | $21,192,000 | +21.7% | 1,274,332 | +10.9% | 0.31% | 0.0% |
| Q3 2013 | $17,412,000 | – | 1,149,332 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 1,992,085 | $10,877,000 | 8.55% |
| Boxer Capital, LLC | 757,935 | $4,138,000 | 3.67% |
| Avoro Capital Advisors LLC | 1,214,833 | $6,633,000 | 1.47% |
| Broadfin Capital, LLC | 693,863 | $3,788,000 | 0.37% |
| ACUTA CAPITAL PARTNERS, LLC | 125,000 | $683,000 | 0.33% |
| RTW INVESTMENTS, LP | 131,052 | $716,000 | 0.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,000 | $819,000 | 0.21% |
| QVT Financial LP | 509,750 | $2,783,000 | 0.19% |
| Baker Brothers Advisors | 2,269,198 | $12,390,000 | 0.13% |
| Ghost Tree Capital, LLC | 75,000 | $410,000 | 0.12% |